Clicky

Olympus Corporation(OLY1)

Description: Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials, such as synthetic bone filler, and orthopedic equipment. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan.


Keywords: Surgery X Ray Urology Endoscopy Diagnostic Gastroenterology Energy Devices Endoscope Olympus Corporation

Home Page: www.olympus-global.com

Shinjuku Monolith
Tokyo, 163-0914
Japan
Phone: 81 3 3340 2111


Officers

Name Title
Mr. Yasuo Takeuchi Representative Executive Officer, ESG Officer & Executive Chairman
Mr. Andre Roggan Executive Officer & CTO
Mr. Tetsuo Kobayashi Executive Officer and Chief Manufacturing & Supply Officer
Mr. Frank Drewalowski Executive Officer & Endoscopic Solutions Division Head
Ms. Gabriela Kaynor Executive Officer & Chief Strategy Officer
Tatsuya Izumi Executive Officer & CFO
Stephen Kneebone Corporate Officer & Chief Information Officer
Mr. Takaaki Sakurai Vice President of Investor Relations
Mr. Neil Boyden Tanner Executive Officer & Global General Counsel
Shigeto Ohtsuki Executive Officer & Chief Human Resources Officer

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 24.9377
Trailing PE: 31.7553
Price-to-Book MRQ: 3.8356
Price-to-Sales TTM: 0.0173
IPO Date:
Fiscal Year End: March
Full Time Employees: 28838
Back to stocks